PPT-Educational Spotlight: Adverse Event Reporting

Event Reporting Adverse Events key points Do not report events EXISTING PRIOR to randomization unless there is a change in severity Report the DIAGNOSIS not the symptoms Fever cough chest pain crackles . OBJECTIVES. Describe Adverse Events, Risks and Problems that can Occur in . H. uman . S. ubjects . R. esearch . C. ompliance with Safety . R. eporting . R. egulations in Clinical Research. Identify Current Systems of Patient Care and Patient Safety in Research. . Word Processing. Chapter 1:. Introduction to Word Processing . Spotlight on Word Processing. Chapter 1. 1. Objectives . Learn uses of word-processing software. Differentiate between typewriter and word-processing software. S. Percy Ivy, MD. Associate Chief, Senior Investigator. Investigational Drug Branch, National Cancer Institute. ivyp@ctep.nci.nih.gov. . National Cancer Institute. . National Cancer Institute. Dee Blumberg, PhD. An adverse event (AE) is any untoward medical occurrence associated with the use of a drug in humans, whether or not considered drug related . (21 CFR 312.32).. Adverse Events. An adverse event or suspected adverse reaction is considered “serious” if, in the view of . . Presentation Overview. PSRT queries. Safety Physicians. Adverse Events. PSRT Query Process. <. 72 . hours. Email to . (. mtn028safetymd@mtnstopshiv.org. ) . Your Protocol Safety Physicians. Devika Singh. S. Percy Ivy, MD. Associate Chief, Senior Investigator. Investigational Drug Branch, National Cancer Institute. ivyp@ctep.nci.nih.gov. . National Cancer Institute. . National Cancer Institute. Holden Comprehensive Cancer Center. Protocol Development and Monitoring . Key definitions. Identifying, documenting and reporting Adverse Events. Investigator Responsibilities . How are research participants protected? . Acknowledgement. Acknowledgment to . Ms. Chun Geok Ying . for preparation of the core contents of this presentation. Outline. Why is safety practices important?. What is safety monitoring? . Safety Reporting. Clinical and Institutional Disclosure of Adverse Events to Patients Call 1 of 2 Delivered May 21, 2012 updated to reflect directive’s reissue (October 31, 2018) Sponsoring Offices: National Center for Ethics in Health Care 2019 Spring. SAFETY of the SUBJECT. Safety of the Subject. Key definitions. Identifying, documenting and reporting. Investigator reporting responsibilities . How are research participants protected? . Educational Support for Mandatory Reporting. Module 1: . Overview of Vanessa’s Law . and Reporting Requirements. Educational Support for Mandatory Reporting. The educational materials provide core content about serious adverse drug reaction (serious ADR) and medical device incident (MDI) reporting that . �� &#x/Att;¬he; [/;ott;&#xom ];&#x/BBo;&#xx [6;.44;i 3;.73; 8;.68;– 4; .76;& ];&#x/Sub;&#xtype;&#x /Fo;&#xoter;&#x /Ty;&#xpe /;&#xPagi;&#xnati Brandon Randolph. Spotlight SAR. In Spotlight mode, the antenna beam is steered to continuously illuminate a desired swath throughout the flight path of the platform.. The central point in the scene is referred to as the motion compensation point (MCP) or scene center.. Investigator Kick-off Meeting. January 30-31, Clearwater, Florida. Jodie Riley, MISM and Robert Silbergleit. Adverse Events. Adverse Events (AEs) are “. . . any . untoward. medical occurrence in a subject that was not previously identified which does not necessarily have a causal relationship to the study drug…” .